The frequency of global crises such as hurricanes, war, and the pandemic makes a standing committee necessary.
The Community Oncology Alliance (COA) has launched a new standing Humanitarian Aid Committee, which will coordinate aid for those affected by war, natural disasters, and other crises. The group’s first effort will be supporting 4 medical charities that are assisting those affected by the war in Ukraine: Americares, Direct Relief, Doctors Without Borders, and International Medical Corps. A webpage for the committee can be found here.
A statement from COA released Monday says that although the group’s mission is based in the United States, “the greater oncology community has a responsibility to act and engage on a global scale during times of crisis.” COA has worked with other groups on hurricane relief efforts and on the global effort to keep patients safe during the COVID-19 pandemic.
The frequency of such events makes a standing committee necessary, the group said.
“Cancer isn’t localized to one country or region of the world, and it certainly doesn’t become less important during times of crisis,” said Mark Thompson, MD, COA’s medical director of public policy. “As people are displaced and seek shelter, it’s our responsibility to help them continue treatment. Cancer doesn’t stop during an emergency. COA’s mission to fight cancer doesn’t either.”
The Humanitarian Aid Committee will include both volunteers and staff. Current members include:
Study Finds ASCT Similarly Safe, Effective in Older and Younger Patients With Multiple Myeloma
November 30th 2023A real-world study suggests high-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is feasible for appropriately selected elderly patients, with similar results seen in older and younger patients.
Read More
Dr Lucio Gordan Discusses Updated Guidelines Addressing 1q Abnormalities in Multiple Myeloma
October 27th 2023Lucio Gordan, MD, president and managing physician of Florida Cancer Specialists & Research Institute, discusses recently updated clinical guidelines from the National Comprehensive Cancer Network (NCCN) in multiple myeloma, which specifically discuss disease staging and risk stratification and advise clinicians on how to address 1q abnormalities.
Listen
Disease-Modifying Antirheumatic Drugs Linked to Decreased Risk for Autoimmune Thyroid Disease
November 28th 2023A nationwide cohort study linked biologic disease-modifying antirheumatic drugs with decreased risks for the onset of autoimmune thyroid disease in patients with rheumatoid arthritis.
Read More